← Leaderboards
Robert Lindblad
The Emmes Company, Llc
$59,748,609
Attributed
$61,150,683
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.6M · FY2010–21$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$61,150,683 · 6
By mechanism
N01$51,744,044 · 4
OT2$6,602,490 · 1
U01$2,804,149 · 1
Top collaborators
- Peter Russell Dawson3 shared
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Keri Hammel$53,700,408
- Ravinder Anand$5,379,842
- Elizabeth Holly Payne$5,133,237
- Greg Doyle-Wandell$13,880,931
- Donald Stablein$6,357,875
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorServicesAreaTrainingProtocol DevelopmentNational Institute Of Drug AbuseResearch SupportClinical Trials NetworkLaboratoriesMeetingsProtocols DocumentationProgramsBaseResearch PersonnelClinical ResearchQuality AssuranceSpecific Qualifier ValuePharmaceutical ServicesPharmacologic SubstanceDrug TestingCommunitiesConsultationsSymposiumBehavioral
Grant awards (21)
Production Assistance for Cellular Therapies (PACT) - Coordinating Center (CC)$332,978
N01 · FY2021 · HL · contact PI
Sickle Cell Disease Cure Initiative (SCDC)$4,529,314
OT2 · FY2020 · HL · contact PI
CTN CLINICAL COORDINATING CENTER SUPPORT; POP 08/14/20-08/13/21$4,064,070
N01 · FY2020 · DA · contact PI
CTN CLINICAL COORDINATING CENTER - HEAL STUDIES. POP: 8/14/20-2/13/21$2,999,817
N01 · FY2020 · DA · contact PI
CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN. PERIOD OF PERFORMANCE: 08/14/2015-08/13/2020. N01DA-15-2243.$6,278,178
N01 · FY2019 · DA · contact PI
Sickle Cell Disease Cure Initiative (SCDC)$2,073,176
OT2 · FY2019 · HL · contact PI
Production Assistance for Cellular Therapies (PACT) - Coordinating Center (CC)$859,498
N01 · FY2019 · HL · contact PI
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.$4,496,930
N01 · FY2018 · DA · contact PI
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.$4,069,336
N01 · FY2017 · DA · contact PI
Production Assistance for Cellular Therapies (PACT) - Coordinating Center (CC)$791,702
N01 · FY2017 · HL · contact PI
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.$4,069,381
N01 · FY2016 · DA · contact PI
CoFAR Statistical and Clinical Coordinating Center$783,547
U01 · FY2016 · AI
Production Assistance for Cellular Therapies (PACT) - Coordinating Center (CC)$435,831
N01 · FY2016 · HL · contact PI
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.$4,069,454
N01 · FY2015 · DA · contact PI
CoFAR Statistical and Clinical Coordinating Center$809,446
U01 · FY2015 · AI
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI$3,378,969
N01 · FY2014 · DA · contact PI
CoFAR Statistical and Clinical Coordinating Center$1,211,156
U01 · FY2014 · AI
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI$4,188,021
N01 · FY2013 · DA · contact PI
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI$4,528,045
N01 · FY2012 · DA · contact PI
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI$3,798,934
N01 · FY2011 · DA · contact PI
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI$3,382,900
N01 · FY2010 · DA · contact PI